30.04.2015 • News

BASF Trials MDI Precursor Production at Chongqing

BASF has begun trial operations at its 400,000 t/y mononitrobenzene plant at Chongqing, in western China. The new facility will feed the group's integrated MDI complex at the same location. Investment costs for the entire project are pegged at €860 million.

In addition to mononitrobenzene, the site will produce 300,000 t/y of aniline, 400,000 t/y of crude MDI and will also have an MDI splitter with a capacity of 400,000 t/y.

Located in the Chongqing Changshou Chemical Industrial Park, the complex, initially planned to go on stream in 2010, took three and a half years to be approved by Chinese authorities. A planned start-up in 2014 was delayed further by BASF's differences with officials over an increase in gas prices.

MDI is an important component for polyurethanes. BASF is building a new Polyurethane Solutions Systems House at Chongqing.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.